MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC Betriebsaufwand 2011-2026 | OXFD
Betriebsaufwand Jährlich Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 59.4 M | 60.6 M | 85.1 M | 72 M | 57.4 M | 47.4 M | 27.5 M | 21.2 M | 17.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 85.1 M | 17.5 M | 49.8 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 202.97 | -0.04 % | $ 22.5 B | USA |
 |
Celcuity
CELC
|
172 M | $ 89.49 | 1.06 % | $ 4.18 B | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
50.6 M | $ 4.1 | -4.43 % | $ 5.45 M | USA |
 |
Fulgent Genetics
FLGT
|
222 M | $ 18.7 | 0.08 % | $ 576 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 20.51 | -0.92 % | $ 595 M | USA |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 1.6 | -3.03 % | $ 7.08 M | USA |
 |
Illumina
ILMN
|
2.06 B | $ 161.5 | 0.33 % | $ 25 B | USA |
 |
Guardant Health
GH
|
226 M | $ 129.51 | -1.61 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
411 M | $ 22.75 | -0.96 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 146.68 | 0.34 % | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 146.92 | 1.58 % | $ 23.6 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.78 | -0.05 % | $ 420 M | USA |
 |
Natera
NTRA
|
258 M | $ 211.42 | -0.31 % | $ 28.9 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 104.16 | -0.34 % | $ 7.03 B | USA |
 |
Pacific Biosciences of California
PACB
|
600 M | $ 1.33 | 1.15 % | $ 399 M | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 190.12 | 1.39 % | $ 9.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 470.72 | 0.72 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
430 M | $ 11.12 | -0.31 % | $ 1.42 B | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 4.26 | -1.59 % | $ 394 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 9.7 | 1.15 % | $ 866 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.04 | 2.19 % | $ 25.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 79.05 | 3.78 % | $ 4.73 B | USA |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 7.34 | 2.16 % | $ 306 M | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
181 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.05 | - | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 265.64 | -0.2 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 473.34 | 0.95 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.65 | - | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 9.24 | 1.54 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |